QUIVADLA Trademark

Trademark Overview


On Tuesday, April 5, 2016, a trademark application was filed for QUIVADLA with the United States Patent and Trademark Office. The USPTO has given the QUIVADLA trademark a serial number of 86965116. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 15, 2019. This trademark is owned by Pfizer Inc.. The QUIVADLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
quivadla

General Information


Serial Number86965116
Word MarkQUIVADLA
Filing DateTuesday, April 5, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 15, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 11, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, April 15, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 15, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 9, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 9, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 8, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, December 8, 2016LETTER OF SUSPENSION E-MAILED
Thursday, December 8, 2016SUSPENSION LETTER WRITTEN
Wednesday, June 8, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 8, 2016LETTER OF SUSPENSION E-MAILED
Wednesday, June 8, 2016SUSPENSION LETTER WRITTEN
Tuesday, June 7, 2016ASSIGNED TO EXAMINER
Monday, April 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 8, 2016NEW APPLICATION ENTERED IN TRAM